Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Regeneron Pharmaceuticals (REGN) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 41 quarters since 2011. Compare with REGN stock chart to see long term trends.

REGN stock compared to

REGN Income Statement

Revenue, Net:2528700000
Revenue Per Share:23.99
Selling, General & Admin Expense:405600000
Research & Development Expense:742900000
Total Operating Expenses:1416000000
Operating Income:1253000000
Income Taxes:137800000
Net Income:1115200000
Earnings Per Share, Basic:10.58
Shares Outstanding, Basic Avg:105400000

REGN Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:67400000
Change in Accounts Receiveable:58300000
Net Cash from Operations:668500000
Repurchases/Buybacks Common Stock:306900000
Net Cash from Financing Activities:-366400000
Property, Plant & Equipment Purchases:115300000
Net Cash from Investing Activities:-1059000000
Net Change in Cash & Equivalents:-756900000

REGN Balance Sheet

Cash and Cash Equivalents:1450400000
Short-Term Investments:2065900000
Accounts Receivable, Net:4173000000
Inventories:2164700000
Total Current Assets:10055100000
Property, Plant & Equipment, Net:3262600000
Total Assets:17772200000
Accounts Payable:null
Total Short-Term Liabilities:3217800000
Long Term Debt, Non-Current Portion:1978900000
Total Liabilities:5795200000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
FMR LLC
12,718,308 sh
254,828 sh
2%
$7,119,454
-$653,395
Blackrock Inc.
9,792,052 sh
2,479 sh
0%
$5,481,395
-$623,872
Vanguard Group Inc
7,988,228 sh
143,233 sh
2%
$4,471,650
-$420,880
Wellington Management Group Llp
3,478,527 sh
-185,341 sh
-5%
$1,947,211
-$337,760
Northern Trust Corp
1,286,702 sh
61,531 sh
5%
$720,271
-$43,806
Bank Of America Corp /De/
1,208,900 sh
1,203,900 sh
24078%
$676,717
$673,599
Renaissance Technologies LLC
1,072,362 sh
182,262 sh
20%
$600,287
$45,176
American Century Companies Inc
929,804 sh
31,333 sh
3%
$520,486
-$39,845
Price T Rowe Associates Inc /Md/
913,992 sh
-209,394 sh
-19%
$511,634
-$188,966
Sands Capital Management, LLC
856,472 sh
17,057 sh
2%
$479,436
-$44,065
Sands Capital Management, LLC
856,472 sh
17,057 sh
2%
$479,436
-$44,065
Legal & General Group Plc
683,247 sh
-9,181 sh
-1%
$382,467
-$49,348
Harris Associates L P
666,295 sh
-560,926 sh
-46%
$372,979
-$392,378
UBS Asset Management Americas Inc
592,199 sh
90,142 sh
18%
$331,501,157
$18,393,309
Goldman Sachs Group Inc
536,944 sh
527,844 sh
5800%
$300,571
$294,896
Charles Schwab Investment Management Inc
510,164 sh
38,641 sh
8%
$285,580
-$8,486
Morgan Stanley
350,736 sh
-9,476 sh
-3%
$196,336
-$28,311
Invesco Ltd.
290,247 sh
31,119 sh
12%
$162,474
$869
FIL Ltd
284,359 sh
-278,104 sh
-49%
$159,179
-$191,601
Ameriprise Financial Inc
276,606 sh
4,209 sh
2%
$154,843
-$14,999

Data imported from Regeneron Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.